Guidance on osteoporosis

NOGG guideline should be implemented

BMJ 2008; 337 doi: 10.1136/bmj.a2691 (Published 25 November 2008)
Cite this as: BMJ 2008;337:a2691

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Jon H Tobias, president elect, Bone Research Society1,
  2. Adam Bajkowski, president2,
  3. Pamela Holmes, chief executive officer3,
  4. Anthony Nunn, chair4,
  5. Diana Moran, president5,
  6. Judy Stenmark, chair6,
  7. Clare Marx, president7,
  8. John Wass, chair8,
  9. Roy Jones, director9
  1. 1Academic Rheumatology, Avon Orthopaedic Centre, Southmead Hospital, Bristol BS10 5NB
  2. 2Primary Care Rheumatology Society
  3. 3Help the Aged
  4. 4Osteoporosis 2000
  5. 5Osteoporosis Dorset
  6. 6Committee of National Societies, International Osteoporosis Foundation
  7. 7British Orthopaedic Association
  8. 8Society for Endocrinology
  9. 9Research Institute for the Care of Older People
  1. Jon.Tobias{at}bristol.ac.uk

    During the protracted development of guidance on osteoporosis from the National Institute for Health and Clinical Excellence (NICE),1 the appraisal committee has disregarded input from public and professional bodies alike. When the guidance is at odds with clinical judgment and patients’ best interests, requiring that patients identified at …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL